High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion
- PMID: 32299867
- PMCID: PMC7163690
- DOI: 10.1183/13993003.00892-2020
High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion
Abstract
Bio-aerosol dispersion via high-flow nasal cannula shows a similar risk to standard oxygen masks. High-flow nasal prongs with a surgical mask on the patient's face might benefit hypoxaemic COVID-19 patients without added risk for the environment.
Conflict of interest statement
Conflict of interest: J. Li has nothing to disclose. Conflict of interest: J.B. Fink is the Chief Science Officer of Aerogen Pharma Corp. Conflict of interest: S. Ehrmann reports grants, personal fees and non-financial support from Fisher and Paykel, during the conduct of the study; grants, personal fees and non-financial support from Aerogen Ltd, personal fees and non-financial support from La diffusion technique française, grants from Hamilton medical, outside the submitted work.
Comment in
-
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion.Eur Respir J. 2020 Oct 8;56(4):2003004. doi: 10.1183/13993003.03004-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32859674 Free PMC article.
-
High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion.Eur Respir J. 2020 Oct 8;56(4):2003136. doi: 10.1183/13993003.03136-2020. Print 2020 Oct. Eur Respir J. 2020. PMID: 32859677 Free PMC article.
Comment on
-
Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial.J Hosp Infect. 2019 Jan;101(1):84-87. doi: 10.1016/j.jhin.2018.10.007. Epub 2018 Oct 15. J Hosp Infect. 2019. PMID: 30336170 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous